Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Cirius Therapeutics gets $30mm in first closing of Series A round

Executive Summary

Cirius Therapeutics Inc. (formerly Octeta Therapeutics; developing a treatment for nonalcoholic steatohepatitis) raised $30mm through the first closing of what the company hopes will turn out to be a $40mm Series A round. Frazier Healthcare Partners and Novo AS led, and were joined by Adams Street Partners, Renaissance Venture Capital Fund, and Hopen Life Science Ventures. Fraizer and Novo get seats on the company’s board.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies